Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma
Part of paid clinical trials in Fort Myers, Florida.
- Sponsor
- SCRI Development Innovations, LLC
- Study ID
- NCT00323739
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- bevacizumab — DRUGBevacizumab 10mg/kg, IV infusion, every 2 weeks
- RAD001 — DRUGRAD001 10 mg by mouth daily
Study Details
This phase II trial will evaluate the combination of bevacizumab + RAD001 in patients with metastatic renal cell carcinoma. In this trial the investigators will evaluate this combination in patients previously untreated with any anti-angiogenesis agent and patients who have previously received one prior regimen containing an anti-angiogenesis agent.
Key Dates
- First listed
- May 9, 2006
- Start date
- May 31, 2006
- Status verified
- Jul 2013
- Primary completion
- Nov 30, 2008
- Completion
- Mar 31, 2011
Study Design
- Enrollment
- 80 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Bevacizumab and RAD001Bevacizumab 10mg/kg, IV infusion, every 2 weeks RAD001 10 mg by mouth daily
Primary Outcome Measure
Progression Free Survival (PFS), the Length of Time, in Months, That Patients Were Alive From Their First Date of Protocol Treatment Until Worsening of Their Disease [ Time Frame: 18 months ]
Locations (12)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Florida Cancer Specialists | Fort Myers | Florida | 33901 | - |
| Gainsville Hematology Oncology Associates | Gainesville | Florida | 32605 | - |
| Integrated Community Oncology Network | Jacksonville | Florida | 32256 | - |
| Florida Hospital Cancer Institute | Orlando | Florida | 32804 | - |
| Wellstar Cancer Research | Marietta | Georgia | 30060 | - |
| Consultants in Blood Disorders and Cancer | Louisville | Kentucky | 40207 | - |
| Baton Rouge General Medical Center | Baton Rouge | Louisiana | 70806 | - |
| Grand Rapids Clinical Oncology Program | Grand Rapids | Michigan | 49503 | - |
| Methodist Cancer Center | Omaha | Nebraska | 68114 | - |
| Oncology Hematology Care | Cincinnati | Ohio | 45242 | - |
| Chattanooga Oncology Hematology Associates | Chattanooga | Tennessee | 37404 | - |
| Tennessee Oncology, PLLC | Nashville | Tennessee | 37023 | - |
Find similar trials in Fort Myers, FL
By condition
By research site
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- NSAID Use After Robotic Partial NephrectomyPHASE2 · Recruiting · University of Miami · Miami, Florida
- A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab MonotherapyPHASE1/PHASE2 · Recruiting · 7 Hills Pharma, LLC · Aurora, Colorado
- A Study of VET3-TGI in Patients With Solid TumorsPHASE1 · Recruiting · KaliVir Immunotherapeutics · Los Angeles, California